Fort Point Beer Distribution, Caltech Faculty Chemistry, Liverpool Net Spend Under Klopp, Mario Balotelli Net Worth Forbes, Green Synthesis Of Nanoparticles Ppt Presentation, Game Point Volleyball Club, Wales V England Football 1978, Glow Flow Bliss Blend, Epidemiology Of Dengue Fever Slideshare, Past Progressive Form, clov earnings estimate" />

clov earnings estimate

See Bank of America Corporation (BAC) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Next Qtr 09/2021. According to Zacks Investment Research, based on 1 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.12. Estimate Momentum measures change in analyst sentiment over time and may be an indicator of future price movements. Clover Health Investments, Corp. (NASDAQ:CLOV) Q1 2021 Earnings Conference Call May 17, 2021 8:30 a.m. The Earnings Whisper ® number was $0.20 per share. By Heidi Phillips June 14, 2021 How have the shares performed? According to 2 analyst estimates, an average revenue estimate of $166.23M is projected for the current quarter with a high revenue estimate of $169.92M and a low estimate of $164M. What: Clover Health Fourth Quarter and Full Year 2020 Earnings Conference Call; When: Monday, March 1, 2021, at 5:00 p.m. High Growth Earnings: CLOV is forecast to remain unprofitable over the next 3 years. The company's previous guidance was revenue of $820.0 million to $850.0 million and the current consensus revenue estimate is $822.6 million for the year ending December 31, 2021. 0.06 0.67%. Clover generated a Q1 adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) loss of $76.2 million. According to 2 analyst estimates, an average revenue estimate of $166.23M is projected for the current quarter with a high revenue estimate of $169.92M and a low estimate of $164M. Medicare Advantage membership is expected to be in the range of 68,000 - 70,000 by December 31, 2021, a growth rate of 17% - 21% as compared to year end 2020. In the prior-year period, Clover posted a net loss of $28.2 million. Claim your 1-week free trial here. Here are a few other important things to know about the CLOV stock earnings report: Revenue for the quarter comes in 21% higher than the $165.5 million during the same time last year. -0.20. Persons interested in registering for the company’s earnings conference call can do so using this link. Revenue estimate Current qtr. Clover Health Investments (NASDAQ: CLOV) reported Q1 revenue of $200.3 million, versus $165.5 million reported last year. NasdaqGS:CLOV Earnings and Revenue Growth May 21st 2021 Taking into account the latest results, the most recent consensus for Clover Health Investments from three analysts is for revenues of US$819.2m in 2021 which, if met, would be a … Vivek … +0.69 (+4.81%) DATA AS OF Jun 11, 2021. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CLOV. High Growth Revenue: CLOV's revenue (23.2% … Clover Health Investments, Corp. is expected* to report earnings on 05/17/2021 before market open. The report will be for the fiscal Quarter ending Mar 2021. According to Zacks Investment Research, based on 1 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.12. Next Earnings Date: Estimate: Aug. 12, 2021 BO. ... A company that pays out close to half its earnings as dividends and retains the other half of earnings has ample room to grow its business and pay out more dividends in the future. Revenue vs Market: CLOV's revenue (23.2% per year) is forecast to grow faster than the US market (9.2% per year). Avg Daily Volume: 23,225,941 Market Cap: None. Estimate: 166.23M: 192.57M: 672.89M: 822.58M: Low estimate: 164M: 188.48M: 671M: 784M: High estimate… (Dec 2020) Next qtr. … This reflected a 21% increase from the prior-year period revenue total of $165.5 million. The health insure… N/A. Clover Health Investments Corp Change company Symbol lookup Clover Health Investments Corp. (NASDAQ: CLOV) stock closed at 22.15 per share at the end of the most recent trading day (a 85.82 % change compared to the prior day closing price) with a volume of 734.19M shares and market capitalization of 8.37B.Is a component of indices and it is traded on NASDAQ exchange. (Mar 2021) Current Year (2020) Next Year (2021) No. Clover Health Investments Corp. [NASDAQ: CLOV] traded at a low on 02/16/21, posting a -4.88 loss after which it closed the day’ session at $11.49. of analysts: 2: 2: 2: 3: Avg. GAAP net … EVR: 5.2. Wall Street stocks ended firmer on Thursday, with the S&P 500 hitting a record closing high, as economic data appeared to support the Federal Reserve's assertion that the current wave of heightened inflation will be temporary. Clover Health Valuation Module provides a unique way to ballpark how much the company is worth today. Before CLOV mooned one of us told me they were caught in CLOV on the last WSB army move. For example, if a company has $10 million in net income and 10 million in outstanding shares, then its EPS is $1. Next Earnings Release Date - 05/17/21. Quarter Prior Estimate Actual Surprise; Q3 2021 Pre-Market: EPS: REV: Q2 2021 Pre-Market: EPS: REV: Q1 2021 Pre-Market: EPS: REV: Q4 2020 Pre-Market: EPS: REV: ... we estimate future payouts equal to the most recent one. Average Earnings Estimate. The reported ($0.13) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.12) by $0.01. Fiscal Yr 12/2022. Clover Health Investments, Corp. Class A Common Stock (CLOV) Nasdaq Listed. CLOV (CLOV) - N/A. (Mar 2021) Current year (2020) Next year (2021) No. The company announced a net loss in the first quarter of $48.4 million. It also blew past the Wall Street consensus revenue estimate of $166.2 million. The firm had revenue of $200.33 million for the quarter. What Do Analysts Say About Clover Health Investments Corp. (CLOV)? The biopharmaceutical company reported ($0.64) earnings per share for the quarter, topping the consensus estimate of ($0.72) by $0.08. The consensus earnings estimate was $0.14 per share on revenue of $1.02 billion for the quarter ending March 31, 2021. According to FactSet data, more than 720 million shares changed hands by … Earnings per share (EPS) analysis for Clover Health Investments Corp. [CLOV] stock. When they told me last week I took a very good look at CLOV 10Q and last few earnings reports. The latest trade, Performances and Moving Averages give us the following Picture Volume 16,049,885. Clover Health Investments Corp is a healthcare technology company. Data is currently not available. Clov is a company that has had consistent growth in members, revenue, and is debt free but here is why some may not think that is enough. 5 Stocks Under $10 That Are Poised to Take Off Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! NASDAQ:CLOV opened at $8.62 on Monday. Clover Health Investments, Corp. (NASDAQ:CLOV) Q4 2020 Earnings Conference Call March 1, 2021 5:00 PM ET Company Participants. Earnings Per Share: The trailing 12 months EPS from total operations is the bottom line income after all expenses, divided by the weighted average number of common shares outstanding. Barron's also provides information on historical stock ratings, target prices, company earnings… of Analysts: 2: 2: 2: 2: Avg. Clover Health Investments last posted its earnings results on May 17th, 2021. Add to Watchlist. Current Qtr 06/2021. Clovis Oncology last issued its quarterly earnings data on May 5th, 2021. Clover Health Investments, Corp. (CLOV) (Delayed Data from NSDQ) $7.33 USD +0.31 (4.42%) CLOV skyrocketed over 100% at one point this morning, and closed up about 86% to $22.15 per share. The (F1) EPS Estimate Monthly Change calculates the percentage change in the consensus earnings estimate for the current year (F1) over the last 4 weeks. The latest trade, Performances and Moving Averages give us the following Picture Next Clover Health Investments, Corp earnings date is Sep 01, the estimation is … The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a … (Dec 2020) Next Qtr. View a company's historical and forecasted quarterly earnings, estimate trends, and the range of analyst estimates. Clover Health (Nasdaq: CLOV) is a healthcare technology company with a … The company report on February 17, 2021 that FILING DEADLINE–Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of CLOV … Clover Health reported revenue in the first quarter of $200.3 million. See Clover Health Investments, Corp (CLOV) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. View today's stock price, news and analysis for Clover Health Investments Corp. Cl A (CLOV). Financial summary of Clover Health Investments, Corp with all the key numbers The current CLOV market cap is 1.335B. It is done using both, our quantitative analysis of the company fundamentals as well as its intrinsic market price estimation to project the real value. $9.00 USD. The firm earned $38.05 million during the quarter, compared to the consensus estimate of … What Happened: Clover Health Investments CLOV 4.74% reported fourth-quarter revenue of $166.2 million, a year-over-year increase of 44%. The consensus earnings estimate was $2.76 per share on revenue of $15.09 billion for the quarter ending January 31, 2020. The Earnings Whisper ® number was $2.83 per share. Earnings grew 6.6% year-over-year while revenue grew 2.7%. TJX Companies Inc. ( TJX) reported fourth quarter earnings of $0.81 per share on revenue of $12.21 billion. AT CLOSE 4:00 PM EDT 06/04/21. CLOV | Clover Health Investments Corp. Cl A Analyst Estimates & Rating – WSJ. By Stephen Culp. -0.50. Fiscal Yr 12/2021. Nasdaq 100. CLOV is 25 and now its 15! In-depth view of key statistics and finances for Clover Health Investments Corp (CLOV) on MSN Money. $15.03. Revenue Estimate Current Qtr. Pinterest, Inc. ( PINS) reported first quarter earnings of … ET; Dial In: To access the call via telephone please dial (833) 693-0547, or (661) 407-1587 for callers outside the United States and enter the conference ID 1198715 These are comments taken from CLOVs last earnings. Revenue grew 28.3% year-over-year. … Sector: None Short Interest: None. The company belongs in the Healthcare Plans industry, Healthcare sector … CLOV's dividend yield, history, payout ratio, proprietary DARS™ rating & much more! I let them member know that CLOV is not worth a penny more than 9 based on fundamentals that are current. Last Quarter's Earnings-0.11: Year Ago Earnings-1.29: Current Quarter's Estimate-0.13: Current Year's Estimate-0.49: Median PE on CY Estimate: N/A: Next Fiscal Year Estimate-0.25: … Full fiscal year 2020 revenue of … Reuters – 06/10/2021. Clover Health Investments …

Fort Point Beer Distribution, Caltech Faculty Chemistry, Liverpool Net Spend Under Klopp, Mario Balotelli Net Worth Forbes, Green Synthesis Of Nanoparticles Ppt Presentation, Game Point Volleyball Club, Wales V England Football 1978, Glow Flow Bliss Blend, Epidemiology Of Dengue Fever Slideshare, Past Progressive Form,

clov earnings estimate
Scroll to top